Literature DB >> 11849217

Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature.

K F Wong1, J C W Chan, H S Y Liu, C Man, Y L Kwong.   

Abstract

Cytogenetic information on T-cell large granular lymphocyte leukaemia (T-LGL; large granular lymphocytosis) is limited. We report two cases of T-LGL with unusual karyotypic aberrations. The first case showed a novel inv(7)(p15q22) as the sole chromosomal abnormality, while the second case showed an inv(14)(q11q32) with evidence of clonal evolution. The breakpoints 7p14-p15 and 14q11 coincide with the T-cell receptor (TCR)-gamma and TCR-alpha/TCR-delta gene loci respectively. This is the first report describing the possible involvement of T-cell receptor genes in karyotypic aberrations in T-LGL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849217     DOI: 10.1046/j.0007-1048.2001.03315.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Rituximab-associated neutropenia.

Authors:  Kieron Dunleavy; Kevin Tay; Wyndham H Wilson
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 2.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

Review 3.  Large granular lymphocyte leukemia.

Authors:  Lubomir Sokol; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

Review 4.  [T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].

Authors:  F Moosig; R Schoch; M Kneba
Journal:  Z Rheumatol       Date:  2006-09       Impact factor: 1.372

5.  Expression of the Tpl2/Cot oncogene in human T-cell neoplasias.

Authors:  Anna V Christoforidou; Helen A Papadaki; Andrew N Margioris; George D Eliopoulos; Christos Tsatsanis
Journal:  Mol Cancer       Date:  2004-12-03       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.